| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $935.3M | +6.9% |
| Cost of Revenue | $396.3M | +12.4% |
| R&D Expense | $88.4M | -8.1% |
| SG&A Expense | $159.1M | +11.6% |
| Operating Income | $68.7M | +0.5% |
| Pre-tax Income | $62.5M | -48.9% |
| Income Tax | $26.6M | +118.2% |
| Net Income | $35.9M | -67.4% |
| EPS (Basic) | $1.02 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $111.3M | +10.7% |
| Accounts Receivable | $95.2M | +4.5% |
| Current Assets | $256.0M | -12.5% |
| Total Assets | $1.31B | +26.4% |
| Current Liabilities | $625.3M | +38.2% |
| Long-term Debt | $119.6M | — |
| Total Liabilities | $790.8M | +55.4% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $32.6M | -76.8% |
| Capital Expenditures | $47.2M | +5.8% |
| Investing Cash Flow | -$166.2M | -205.9% |
| Financing Cash Flow | $150.1M | +246.1% |
| Free Cash Flow | -$14.6M | -115.2% |
| -66.8% |
| EPS (Diluted) | $1.01 | -66.8% |
| Stockholders' Equity |
| $518.4M |
| -1.7% |